De­spite the rise of a vac­cine skep­tic in the cam­paign of US pres­i­den­tial elec­tion win­ner Don­ald Trump, GSK CEO Em­ma Walm­s­ley be­lieves her com­pa­ny can … ...

Emma Walmsley, CEO of GSK leading the keynote at the FT Live Global Pharma and Biotech Summit in London. Credit: Jenna Philpott / GlobalData. Following Donald Trump’s re-election as the 47 th ...

With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history ...

The global methylparaben market is projected to expand steadily over the next decade, according to a recent report by Future Market Insights (FMI). The market, valued at USD 1,440 million in 2024, is ...

Full Year 2024 Guidance: 7% to 9% sales growth, 11% to 13% profit growth. GSK PLC (NYSE:GSK) reported a 9% sales growth and 19% profit growth year-to-date, reflecting strong performance in ...